Alibaba and AUS Merchant Services agree to pay $600 million to settle US Justice Department probe into illegal drug sales.
Alibaba and its US-based payment processor AUS Merchant Services entered into non-prosecution agreements with the US Justice Department, agreeing to pay $600 million to resolve allegations they failed to prevent illegal drug sales on their platforms. Alibaba admitted that between 2016 and 2024, it failed to prevent approximately 80,000 transactions involving illegal pharmaceuticals, chemicals, and counterfeiting equipment imported into the US. The companies agreed to accept responsibility and enhance their compliance programs.
9
Divergence score
3 outlets covered it, splitting into 3 framing camps across 2 bias groups.
By each outlet's earliest publish time in this story. Feeds that index slowly can appear later than they printed.
The split, in one line
Al Jazeera and SCMP emphasize Alibaba's full cooperation and the thorough regulatory process, while WSJ's headline centers on the DOJ settlement over illegal drug sales.
How each outlet covered it
Lightly covered so far
Too few outlets to map a left-right split. Here is each take as it stands.
Sparse coverage · 3 outlets
AJAl JazeeraINTERNATIONAL71d ago
“Alibaba to pay $600m to settle illegal drug sales allegations in US probe”
SCSouth China Morning PostINTERNATIONAL71d ago
“Alibaba agrees to pay US$600 million to settle US probe into illegal product sales”
WSJWall Street JournalRIGHT-CENTER71d ago
“Alibaba, U.S. Payment Processor to Pay $600 Million in DOJ Settlement Over Illegal Drug Sales”
6 tracked claims across 3 outlets
Fact ledger
All6Claimed3Corroborated3
1/3
Claimed
The illegal transactions had a combined merchandise value of more than $200 million.
